Clinical Trials Browser

Drug-Related Side Effects and Adverse Reactions × Drug Therapy × Gynecologic × Clear all

NCT04635956 2020-11-19

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Phase 2 Unknown

Uterine Cervical Neoplasms, Drug-Related Side Effects and Adverse Reactions